(Q37327072)

19 August 2017

1 reference

title

Epidemiology of invasive fungal infection (English)

1 reference

invasive fungal infections

19 August 2017

1 reference

1 reference

J J Castón-Osorio

1

1 reference

19 August 2017

A Rivero

series ordinal

2

1 reference

19 August 2017

J Torre-Cisneros

series ordinal

3

1 reference

19 August 2017

publication date

1 November 2008

1 reference

International Journal of Antimicrobial Agents

19 August 2017

published in

1 reference

19 August 2017

volume

32 Suppl 2

1 reference

19 August 2017

page(s)

S103-9

1 reference

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Cryptococcosis in organ transplant recipients: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Taxonomic position of deep-seated, mucosa-associated, and superficial isolates of Trichosporon cutaneum from trichosporonosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Infections due to emerging and uncommon medically important fungal pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Nosocomial infection due to Trichosporon asahii: clinical revision of 22 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Trichosporon beigelii, an emerging pathogen resistant to amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

In vitro antifungal susceptibilities of Trichosporon species.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

In-vitro comparative activity of fluconazole and other antifungal agents against Blastoschizomyces capitatus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Genotyping and antifungal susceptibility profile of Dipodascus capitatus isolates causing disseminated infection in seven hematological patients of a tertiary hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Rhodotorula rubra peritonitis in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Rhodotorula glutinis-related meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Rhodotorula glutinis keratitis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion test

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Risk of Fungemia Due to Rhodotorula and Antifungal Susceptibility Testing of Rhodotorula Isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Primary central nervous system phaeohyphomycosis: a review of 101 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Infections due to dematiaceous fungi in organ transplant recipients: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Alternariosis after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Subcutaneous black fungus (phaeohyphomycosis) infection in renal transplant recipients:three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Emergence of black moulds in fungal disease: epidemiology and therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

The Effect of Prophylactic Fluconazole on the Clinical Spectrum of Fungal Diseases in Bone Marrow Transplant Recipients with Special Attention to Hepatic Candidiasis: An Autopsy Study of 355 Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Why prior fluconazole use is associated with an increased risk of invasive mold infections in immunosuppressed hosts: an alternative hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Isolation of Aspergillus spp. from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Invasive aspergillosis in the intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Late-onset invasive aspergillosis in organ transplant recipients in the current era.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Risk factors for treatment failures in patients receiving PCR-based preemptive therapy for CMV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Trends in Risk Profiles for and Mortality Associated with Invasive Aspergillosis among Liver Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Risk Factors for Invasive Aspergillosis in Solid-Organ Transplant Recipients: A Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Fusarium infection after solid-organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

1 reference

7 January 2021

Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Fusarium infections in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist*

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Pulmonary scedosporium infection following lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

In vitro activities of four novel triazoles against Scedosporium spp

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium Prolificans Spanish Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Disseminated phaeohyphomycosis: review of an emerging mycosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Rhinocerebral and systemic mucormycosis. Clinical experience with 36 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

Advances and challenges in management of invasive mycoses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2808%2970009-8

7 January 2021

10.1016/S0924-8579(08)70009-8

Identifiers

DOI

1 reference

19 August 2017

1 reference